Vanguard Group Inc Annexon, Inc. Transaction History

Vanguard Group Inc

$4.96 Trillion
Q1 2024

A detailed history of Vanguard Group Inc transactions in Annexon, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,747,655 shares of ANNX stock, worth $18.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,747,655

Previous 1,908,326 96.38%

Holding current value

$18.1 Million

Previous $8.66 Million 210.17%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$4.03 - $7.81 $7.41 Million - $14.4 Million	1,839,329 Added 96.38%	3,747,655 $26.9 Million
Q4 2023 Feb 14, 2024	BUY	$1.63 - $4.63 $22,684 - $64,435	13,917 Added 0.73%	1,908,326 $8.66 Million
Q3 2023 Nov 14, 2023	BUY	$2.13 - $3.84 $308,081 - $555,413	144,639 Added 8.27%	1,894,409 $4.47 Million
Q2 2023 Aug 14, 2023	BUY	$2.1 - $6.37 $377,577 - $1.15 Million	179,799 Added 11.45%	1,749,770 $6.16 Million
Q1 2023 May 15, 2023	BUY	$3.74 - $7.46 $78,914 - $157,406	21,100 Added 1.36%	1,569,971 $6.04 Million

Q4 2022 Feb 10, 2023	BUY	$4.56 - $6.02 $38,322 - $50,592	8,404 Added 0.55%	1,548,871 $8.01 Million
Q3 2022 Nov 14, 2022	BUY	$3.75 - $6.63 $904,773 - $1.6 Million	241,273 Added 18.57%	1,540,467 $9.52 Million
Q2 2022 Aug 12, 2022	BUY	$2.11 - $4.06 $430,781 - $828,897	204,162 Added 18.64%	1,299,194 $4.9 Million
Q1 2022 May 13, 2022	BUY	$2.73 - $11.94 $53,841 - $235,480	19,722 Added 1.83%	1,095,032 $2.99 Million
Q4 2021 Feb 14, 2022	BUY	$11.49 - $22.0 $625,653 - $1.2 Million	54,452 Added 5.33%	1,075,310 $12.4 Million
Q3 2021 Nov 12, 2021	BUY	$16.35 - $23.4 $1.93 Million - $2.76 Million	117,921 Added 13.06%	1,020,858 $19 Million
Q2 2021 Aug 13, 2021	BUY	$17.81 - $27.48 $16.1 Million - $24.8 Million	902,937 New	902,937 $20.3 Million

Others Institutions Holding ANNX

# of Institutions

138

Shares Held

87.3M

Call Options Held

2.54M

Put Options Held

556K

View Full List

About Annexon, Inc.

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $230M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

More about ANNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Annexon, Inc. Transaction History